[go: up one dir, main page]

MX2017008983A - Composición farmaceútica de sulfonamida. - Google Patents

Composición farmaceútica de sulfonamida.

Info

Publication number
MX2017008983A
MX2017008983A MX2017008983A MX2017008983A MX2017008983A MX 2017008983 A MX2017008983 A MX 2017008983A MX 2017008983 A MX2017008983 A MX 2017008983A MX 2017008983 A MX2017008983 A MX 2017008983A MX 2017008983 A MX2017008983 A MX 2017008983A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
sulfonamide
sulfonamide compound
injectable preparation
present
Prior art date
Application number
MX2017008983A
Other languages
English (en)
Other versions
MX376741B (es
Inventor
Tian Li
Zhao Xinying
Sun Changhai
Juang WU Yi
Han Zhidong
Lin Chuangyu
Yao Xiaoqing
Original Assignee
Tianjin Hongri Jian Da Kang Medical Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Hongri Jian Da Kang Medical Tech Co Ltd filed Critical Tianjin Hongri Jian Da Kang Medical Tech Co Ltd
Publication of MX2017008983A publication Critical patent/MX2017008983A/es
Publication of MX376741B publication Critical patent/MX376741B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composición farmacéutica de sulfonamida. La presente invención se relaciona a una preparación inyectable del compuesto de sulfonamida que comprende un compuesto de sulfonamida o un derivado del mismo. La preparación inyectable es preparada a partir del compuesto de sulfonamida y un portador farmacéuticamente aceptable a través de ciertas tecnologías de preparación. La preparación inyectable del compuesto de sulfonamida involucrada en la presente invención es estable y controlable en calidad y efectiva.
MX2017008983A 2015-01-06 2016-01-04 Composición farmaceútica de sulfonamida MX376741B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510005995.5A CN104473914B (zh) 2015-01-06 2015-01-06 一种磺酰胺类药物组合物
PCT/CN2016/070015 WO2016110225A1 (zh) 2015-01-06 2016-01-04 一种磺酰胺类药物组合物

Publications (2)

Publication Number Publication Date
MX2017008983A true MX2017008983A (es) 2018-03-23
MX376741B MX376741B (es) 2025-03-07

Family

ID=52748619

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008983A MX376741B (es) 2015-01-06 2016-01-04 Composición farmaceútica de sulfonamida

Country Status (12)

Country Link
US (2) US20170354621A1 (es)
EP (1) EP3243510B1 (es)
JP (1) JP6502507B2 (es)
KR (1) KR101949810B1 (es)
CN (2) CN104473914B (es)
AU (1) AU2016206154B2 (es)
CA (1) CA2972834C (es)
MX (1) MX376741B (es)
MY (1) MY200499A (es)
RU (1) RU2715700C2 (es)
SG (1) SG11201705543VA (es)
WO (1) WO2016110225A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473914B (zh) * 2015-01-06 2017-01-11 天津红日药业股份有限公司 一种磺酰胺类药物组合物
US20180055796A1 (en) 2016-08-23 2018-03-01 Gongwin Biopharm Holdings Co., Ltd. Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth
CN113368251A (zh) * 2020-02-25 2021-09-10 上海和绎实业有限公司 一种组合溶剂及其制备方法和应用
US11752160B2 (en) * 2020-09-24 2023-09-12 Gongwin Biopharm Co., Ltd Method for reducing fat by administering benzenesulfonamide compositions
US12109210B2 (en) * 2021-09-29 2024-10-08 Gongwin Biopharm Co., Ltd Methods for treating mast cell tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891454A (en) * 1997-03-28 1999-04-06 Alexander Wu Anti-cancer drug and special tumor necrotizing agent
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
CN1073415C (zh) * 1997-07-03 2001-10-24 吴宜庄 磺酰胺类化合物在制备抗癌药物中的应用
DE69917609T2 (de) * 1998-03-05 2005-06-09 Phares Pharmaceutical Research N.V., Curaçao Arzneimittel und deren verwendung
US6727287B2 (en) 2001-04-16 2004-04-27 Pts International, Inc. Toluene sulfonamide-containing anti-tumor composition and method of use thereof
CN102389410A (zh) * 2011-11-03 2012-03-28 黄漫翔 对-甲苯磺酰胺在制备癌症治疗药物中的应用
CN104473914B (zh) * 2015-01-06 2017-01-11 天津红日药业股份有限公司 一种磺酰胺类药物组合物

Also Published As

Publication number Publication date
CA2972834C (en) 2020-07-14
CN104473914A (zh) 2015-04-01
US20190231721A1 (en) 2019-08-01
JP6502507B2 (ja) 2019-04-17
US11040020B2 (en) 2021-06-22
EP3243510B1 (en) 2022-08-31
AU2016206154A1 (en) 2017-07-27
US20170354621A1 (en) 2017-12-14
EP3243510A4 (en) 2018-08-08
CN107205974A (zh) 2017-09-26
MX376741B (es) 2025-03-07
WO2016110225A1 (zh) 2016-07-14
AU2016206154B2 (en) 2018-11-01
MY200499A (en) 2023-12-28
KR20170095926A (ko) 2017-08-23
JP2018501291A (ja) 2018-01-18
CN104473914B (zh) 2017-01-11
CA2972834A1 (en) 2016-07-14
EP3243510A1 (en) 2017-11-15
SG11201705543VA (en) 2017-08-30
KR101949810B1 (ko) 2019-02-19
RU2017126976A (ru) 2019-02-08
RU2017126976A3 (es) 2019-08-22
RU2715700C2 (ru) 2020-03-03

Similar Documents

Publication Publication Date Title
CL2016001120A1 (es) Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
CL2018000684A1 (es) Moduladores de la proteína de núcleo de la hepatitis b.
MX2017002028A (es) Compuestos de pirrolopirimidina usados como agonista del receptor de tipo toll 7 (tlr7).
CU20150071A7 (es) Composición de liberación demorada que comprende biguanida
MX2018005708A (es) Compuesto de 7-(tiazol-5-il)pirrolopirimidina como agonista de tlr7.
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
EA201591591A1 (ru) Соединения карбазола, применяемые в качестве ингибиторов бромодомена
MX2016003199A (es) Compuestos de azapiridona y usos de los mismos.
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
EA201790630A1 (ru) Способы получения рибозидов
CO2018005920A2 (es) Composiciones y métodos para fabricar micropartículas de proteína
EA201691582A1 (ru) Новые фармацевтические препараты
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
EA201591524A1 (ru) Производные 2-аминопиримидина для лечения вирусных инфекций
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
UY35300A (es) Formulación de combinación de dos compuestos antivirales
CR20120418A (es) Inhibidores de virus flaviviridae
GT201500247A (es) Imidazopiridazinas sustituidas
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
DOP2017000034A (es) Compuestos de imidazopiridazina
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
MX2017008983A (es) Composición farmaceútica de sulfonamida.

Legal Events

Date Code Title Description
FG Grant or registration